| 000 | 01810 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511223328.0 | ||
| 264 | 0 | _c19901213 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0014-5793 | ||
| 024 | 7 |
_a10.1016/0014-5793(90)81089-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHöhne, M | |
| 245 | 0 | 0 |
_aRegulation of cytochrome P-450 CYPIA1 gene expression and proto-oncogene expression by growth factors in primary hepatocytes. _h[electronic resource] |
| 260 |
_bFEBS letters _cOct 1990 |
||
| 300 |
_a219-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGenes _xdrug effects |
| 650 | 0 | 4 |
_aGrowth Substances _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xcytology |
| 650 | 0 | 4 |
_aMethylcholanthrene _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-fos |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-jun |
| 650 | 0 | 4 |
_aProto-Oncogenes _xdrug effects |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor alpha _xpharmacology |
| 700 | 1 | _aBecker-Rabbenstein, V | |
| 700 | 1 | _aKahl, G F | |
| 700 | 1 | _aTaniguchi, H | |
| 773 | 0 |
_tFEBS letters _gvol. 273 _gno. 1-2 _gp. 219-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-5793(90)81089-7 _zAvailable from publisher's website |
| 999 |
_c2127691 _d2127691 |
||